<DOC>
	<DOCNO>NCT02913456</DOCNO>
	<brief_summary>This disease registry prospective , multicenter non-interventional study design observe anti-cancer treatment regimens clinical outcome participant HER2-positive unresectable LA/mBC . Diagnosis unresectable LA mBC 6 month old prior registry enrollment .</brief_summary>
	<brief_title>A European Registry Study Prospectively Observe Treatment Patterns Outcomes Participants With Human Epidermal Growth Factor Receptor 2 ( HER2 ) -Positive Unresectable Locally Advanced ( LA ) Metastatic Breast Cancer ( mBC ) ( SAMANTHA )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Initially diagnose HER2positive unresectable LA/mBC 6 month prior enrollment , although received anticancer treatment time Not applicable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>